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Figure 1 Indicative treatment time comparisons 
 
Conclusions: Co-57 is a viable option for future development 
as a HDR radionuclide while Gd-153 will have limited uses for 
LDR or PDR. Of the commercially available sources little 
differences are observed between Co-60 and Ir-192 physically 
and clinically. The economic benefit of Co-60 is the greatest 
difference but other factors influence the choice of HDR 
equipment over and above the costs for most centres. 
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Purpose/Objective: Brachytherapy of intraocular tumors 
with 125I eye plaques has become a successful treatment 
modality and a viable alternative to enucleation. Plaque 
Simulator (PS) is an eye plaque treatment planning system 
(TPS) that uses TG-43 dosimetry. We aimed to verify the 
performance of the PS routinely used to plan patients having 
intraocular tumors. 
Materials and Methods: Relative dose distributions, including 
central axis depth dose and off axis dose profiles of 
Collaborative Ocular Melanoma Study (COMS) plaques with 
14, 16, 18 and 20 mm in diameter, loaded with model I25.S16 
seeds were measured using 1x1x1 mm3 Thermo Luminesans 
Dosimetry (TLD) cubes and computed using MCNP5 Monte 
Carlo code and Plaque Simulator (PS) TPS. Measurements and 
calculations were compared by normalizing 5 mm distance at 
the central axis of the plaque i.e COMS point. 
Results: For the central axis depth doses, the agreement 
between the measured and calculated dose distributions was 
within 13%, whereas deviations up to 22% were observed in 
single points far off-axis. For central axis dose distribution, 
the max difference among the PS, TLD and MCNP5 results was 
seen at 2 mm from the plaque center for all plaque sizes. For 
off axis dose distribution the maximum dose difference 
among the PS, TLD and MCNP5 results were seen at ± 12 mm 
from the central axis, periphery of the plaque. 
Conclusions: The Bebig Plaque Simulator is a reliable TPS for 
calculating relative dose distributions around realistic 
multiple 125I seed configurations if one understands its 
limitations at the first few milimeters around the plaque 
center and far off axis points. 
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Purpose/Objective: Purpose of this study was to verify the 
spatial dose distribution around a single iridium source using 
dosimetric films and compare the designated distribution 
with data generated by the treatment planning system (TPS). 
The secondary goal was to determine whether such 
measurements may be used to commission model based dose 
calculation algorithms (MBDCA). 
Materials and Methods: To determine the spatial distribution 
dose around the radioactive source radiochromic films MD-55 
were irradiated. Films during irradiation procedure were 
placed at different depths in the phantom and in the 
opposite orientation to the long axis of the source. Measured 
dose distribution has been checked and compared with the 
calculated spatial distribution of dose generated in the 
treatment planning system. The dose calculation has been 
performed according to the TG43 report. To compare two 
images presenting absorbed dose (measured and planned) 
analysis gamma factor has been used. 
Results: Comparison of the measured doses distribution and 
the corresponding dosegrids from TPS has showed that dose 
distribution around source may be measured using 
radiochromic films in certain dose range. The few areas of 
the images showed deviations from the acceptance criteria, 
mainly because of defects of films. 
 
Conclusions: The best matching of the measured and 
